REDUCED BASAL GANGLIA VOLUME ASSOCIATED WITH THE GENE FOR HUNTINGTONS-DISEASE IN ASYMPTOMATIC AT-RISK PERSONS

被引:143
作者
AYLWARD, EH
BRANDT, J
CODORI, AM
MANGUS, RS
BARTA, PE
HARRIS, GJ
机构
[1] JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT & BEHAV SCI,BALTIMORE,MD 21205
[2] TUFTS UNIV,SCH MED,DEPT PSYCHIAT,NEUROIMAGING RES LAB,BOSTON,MA 02111
关键词
D O I
10.1212/WNL.44.5.823
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Previous investigations using linear CT measures found no evidence of caudate atrophy in asymptomatic persons who have the DNA haplotype linked to the Huntington's disease (HD) gene. We measured volumes of the caudate, putamen, and globus pallidus on MRIs of 10 gene marker-positive and 18 gene marker-negative asymptomatic at-risk persons. The volumes of all basal ganglia structures were significantly reduced in the marker-positive group, even after controlling for age, total brain volume, and minor neurologic signs. Discriminant function analysis using basal ganglia volumes and age as predictor variables correctly identified genetic status in 86% of subjects. These results indicate that basal ganglia volume is reduced before individuals become symptomatic with HD.
引用
收藏
页码:823 / 828
页数:6
相关论文
共 37 条
[1]
AYLWARD EH, 1991, AM J NEURORADIOL, V12, P1217
[2]
BICAUDATE INDEX IN COMPUTERIZED TOMOGRAPHY OF HUNTINGTON DISEASE AND CEREBRAL ATROPHY [J].
BARR, AN ;
HEINZE, WJ ;
DOBBEN, GD ;
VALVASSORI, GE ;
SUGAR, O .
NEUROLOGY, 1978, 28 (11) :1196-1200
[3]
BARTA PE, 1990, AM J PSYCHIAT, V147, P1457
[4]
PRESYMPTOMATIC DIAGNOSIS OF DELAYED-ONSET DISEASE WITH LINKED DNA MARKERS - THE EXPERIENCE IN HUNTINGTONS-DISEASE [J].
BRANDT, J ;
QUAID, KA ;
FOLSTEIN, SE ;
GARBER, P ;
MAESTRI, NE ;
ABBOTT, MH ;
SLAVNEY, PR ;
FRANZ, ML ;
KASCH, L ;
KAZAZIAN, HH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (21) :3108-3114
[5]
CARRASCO LH, 1986, LANCET, V1, P1388
[6]
TRINUCLEOTIDE REPEAT LENGTH INSTABILITY AND AGE-OF-ONSET IN HUNTINGTONS-DISEASE [J].
DUYAO, M ;
AMBROSE, C ;
MYERS, R ;
NOVELLETTO, A ;
PERSICHETTI, F ;
FRONTALI, M ;
FOLSTEIN, S ;
ROSS, C ;
FRANZ, M ;
ABBOTT, M ;
GRAY, J ;
CONNEALLY, P ;
YOUNG, A ;
PENNEY, J ;
HOLLINGSWORTH, Z ;
SHOULSON, I ;
LAZZARINI, A ;
FALEK, A ;
KOROSHETZ, W ;
SAX, D ;
BIRD, E ;
VONSATTEL, J ;
BONILLA, E ;
ALVIR, J ;
CONDE, JB ;
CHA, JH ;
DURE, L ;
GOMEZ, F ;
RAMOS, M ;
SANCHEZRAMOS, J ;
SNODGRASS, S ;
DEYOUNG, M ;
WEXLER, N ;
MOSCOWITZ, C ;
PENCHASZADEH, G ;
MACFARLANE, H ;
ANDERSON, M ;
JENKINS, B ;
SRINIDHI, J ;
BARNES, G ;
GUSELLA, J ;
MACDONALD, M .
NATURE GENETICS, 1993, 4 (04) :387-392
[7]
FOLSTEIN M, 1990, FUNCTION DYSFUNCTION, P224
[8]
FOLSTEIN SE, 1983, NEUROBEH TOXICOL TER, V5, P605
[9]
REDUCED STRIATAL GLUCOSE CONSUMPTION AND PROLONGED REACTION-TIME ARE EARLY FEATURES IN HUNTINGTONS-DISEASE [J].
GARNETT, ES ;
FIRNAU, G ;
NAHMIAS, C ;
CARBOTTE, R ;
BARTOLUCCI, G .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1984, 65 (02) :231-237
[10]
SERIAL CHANGES OF CEREBRAL GLUCOSE-METABOLISM AND CAUDATE SIZE IN PERSONS AT RISK FOR HUNTINGTONS-DISEASE [J].
GRAFTON, ST ;
MAZZIOTTA, JC ;
PAHL, JJ ;
STGEORGEHYSLOP, P ;
HAINES, JL ;
GUSELLA, J ;
HOFFMAN, JM ;
BAXTER, LR ;
PHELPS, ME .
ARCHIVES OF NEUROLOGY, 1992, 49 (11) :1161-1167